Welcome to Episode 14 of Beyond the Script: SANA Talks. This week, Dan Lowry is back with Dr Richard Ralph for a deep dive into some of the most exciting and surprising developments in medical weight loss and resistance training. From Saxenda’s exit from the market to new tweaks in Ozempic dosing pens, we’ve got the latest updates you need to know. We also unpack powerful new research on ‘inflammaging’ and how resistance training may fight inflammation as we age. Plus, how do Mounjaro and Wegovy really stack up when it comes to weight loss and side effects? The results may surprise you. Whether you’re a health professional or just passionate about wellness, this episode is packed with insight, clarity and a few curveballs you won’t want to miss. Tune in now and stay ahead in the world of health and longevity!

Ver todos los episodios